While European stocks slide on trade tensions and tariff fears, Bayer shares are moving higher.
Dan Koh and Ryan Huang explain the US Supreme Court decision behind the rally, what the Roundup appeal means for long-running cancer lawsuits, and why this legal development could change the company’s outlook.

Bigger Pic: S&P 7,000 vs. The Hormuz U-Turn
08:33

Mind Your Business: How Jing Chan built sensibilities as a young founder
14:00

Companies To Watch: PepsiCo starts 2026 strong as snack volumes recover
08:52